Sanofi-Aventis

Sanofi-Aventis, headquartered in Paris, France, is a multinational pharmaceutical company, the world's fourth-largest by prescription sales. Sanofi-Aventis engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. Sanofi-Aventis covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur). The company is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Source: Wikipedia

Campaign Finance

$5,331,910 Given
Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

covers roughly through Q4 2013
  • Top Recipients

    PAC Color Block
    Organization's PAC(s)
    Employee Color Block
    Associated Individuals
    Includes contributions from the organization’s employees, their family members, and its political action committee.
  • Republicans vs. Democrats

    in dollars. "Other" includes 3rd parties and organizations without official party affiliation.
  • State vs. Federal

    in dollars
  • Top PAC Recipients

    PAC Color Block
    Organization's PAC(s)
    Employee Color Block
    Associated Individuals
    Includes contributions from the organization’s employees, their family members, and its political action committee.
View all campaign finance data for Sanofi-Aventis Sources: OpenSecrets.org FollowTheMoney.org

Lobbying

$47,725,834 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers roughly through Q4, 2013

Lobbying on Behalf of Sanofi-Aventis

View all lobbying data for Sanofi-Aventis Sources: OpenSecrets.org

Regulations

Mentioned in 372 dockets; Submitted to 97 dockets
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated daily from Regulations.gov by way of Docket Wrench

The tables show occurrences of "Sanofi-Aventis" in public comments on proposed federal regulations.

Contractor Misconduct

9 Instances
Information

This information is collected by the Project On Government Oversight from press releases, court documents, news reports and other public records. It is not meant to be an exhaustive account of all instances of federal contractor misconduct.

More information on each instance, including primary source documents, is available on POGO's site by clicking on the instance description. More information on POGO's methodology is available here.

covers through POGO's March 5, 2013 release
Misconduct Type Hired By Incident Year Disposition Penalty
Health None Fraudulent Pricing of Anzemet 2007 Settlement $190,433,326
Government Contract Fraud None Misreporting Prices for Nasal Sprays 2009 Settlement $95,500,000
Antitrust None Vitamin Cartel - EU Fine 2001 Fine $4,000,000
Health None FDA Inspection of Frankfurt, Germany Facility 2011 Investigative Finding $0
Antitrust None Failure to Report Ambien Patent Agreements 2011 Investigative Finding $0
Health None FDA Inspection of Bridgewater, NJ Facility 2011 Investigative Finding $0
Labor None Bellifemine v. Sanofi-Aventis (Gender Discrimination) 2007 Pending $0
Health International Vitamin Cartel - Australian Class Action 2006 Settlement $0
Health None Cardizem CD Settlement 2005 Settlement $0
View all contractor misconduct data for Sanofi-Aventis Sources: Federal Contractor Misconduct Database from POGO

EPA Violations

2 Enforcement Actions
Information

Figures are based on data from the Environmental Protection Agency’s ECHO website. The ECHO database contains federal and state environmental enforcement actions. Data displayed here includes only those actions that began after 2000 and resulted in fines of over $1 million.

Actions where the company was the sole defendant are listed first. Actions where the company is one of multiple defendants are listed subsequently.

For more information see our EPA methodology page.

covers through EPA's October 19, 2011 release
Case Name Defendant Date Locations Amount
Lwd, Inc. Hoescst Celanese (+84 others) 2007 Calvert City, Ky $10,000,000
Aqua-Tech Environmental, Inc. (Prn) Hoechst (Fka Celanese; Nka Cna Holdings, Inc.) (+169 others) 2006 Greer, Sc $9,170,528
View all EPA violations data for Sanofi-Aventis Sources: EPA ECHO Enforcement Data

Advisory Committees

2 people on 2 committees
Information

Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.

The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.

covers through 2011

Table shows employees of "Sanofi-Aventis" that sat on federal advisory committees.

  • Agency
  • Representation
  • Toggle National Science Foundation 1 person on 1 committee
  • Toggle Department of Veterans Affairs 1 person on 1 committee
View all advisory committee data for Sanofi-Aventis